Results 21 to 30 of about 98,010,213 (261)

Profile of specific antibodies to the SARS-CoV-2

open access: yesJournal of Medical Microbiology, 2021
In this work, we studied the profile of IgM and IgG antibody responses to SARS-CoV-2 in 32 patients with COVID-19 from day 1 to day 24. IgM remained measurable for a much shorter period than IgG, suggesting that IgG antibody may represent the primary immune response.
Mou, Danlei   +7 more
openaire   +3 more sources

Assessment of Anti-SARS-CoV-2 Antibodies Post-Coronavac Vaccination in the Amazon Region of Brazil

open access: yesVaccines, 2021
The present study evaluated the frequency of seropositivity for anti-SARS-CoV-2 (S1 and S2) total antibodies and anti-SARS-CoV-2 (receptor binding domain-RBD-S1) neutralizing antibodies in individuals vaccinated with the immunizing agent Coronavac.
Carlos David Araújo Bichara   +8 more
doaj   +1 more source

Two Opposing Roles of SARS-CoV-2 RBD-Reactive Antibodies in Pre-Pandemic Plasma Samples From Elderly People in ACE2-Mediated Pseudovirus Infection

open access: yesFrontiers in Immunology, 2022
A novel coronavirus designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged and caused an outbreak of unusual viral pneumonia.
Kyu-Young Sim   +14 more
doaj   +1 more source

Individuals identified as positive for anti-SARS-CoV-2 antibodies in the population without registered SARS-CoV-2 infections.

open access: yes, 2022
Individuals identified as positive for anti-SARS-CoV-2 antibodies in the population without registered SARS-CoV-2 infections.
Krystyna Dąbrowska (315930)   +13 more
core   +1 more source

Proyecto Argentino Interinstitucional de genómica de SARS-CoV-2. Reporte Nº 1 Inicial. “Análisis de secuencias de SARS-CoV-2 obtenidas de pacientes con COVID-19 de Argentina” [PDF]

open access: yes, 2020
Hasta el 9 de septiembre 2021 el Proyecto a generado 26 Reportes. Reporte nro 1 - Análisis inicial. Reporte nro 2 – Patagonia. Reportes nro 3 y 4 - CABA y Prov. BsAs. Reporte nro 5 – Córdoba. Reporte nro 6 – Chaco. Reporte UK.
Consorcio Argentino de Genómica de SARS-CoV-2
core   +1 more source

Titration of Neutralizing Antibodies against SARS-CoV-2 in Mice after Prime-Boost Vaccination with rVSV-SARS-CoV-2.

open access: yes, 2021
Titration of Neutralizing Antibodies against SARS-CoV-2 in Mice after Prime-Boost Vaccination with rVSV-SARS-CoV-2.
Taewoo Kim (1456888)   +30 more
core   +1 more source

Neurological Complications in COVID-19 Patients: Can Analysis of Specific Antibodies and Viral RNA in Paired Cerebrospinal Fluid and Serum be Used for Accurate Diagnosis of SARS-CoV-2 Neuroinflammatory Disease? A Case Series

open access: yesClinical Pathology, 2022
Background: Neurological complications during and after SARS-CoV-2 infection have been frequently described. The detection of either SARS-CoV-2 RNA or specific antibodies against SARS-CoV-2 in cerebrospinal fluid in the context of concomitant ...
Karin Holst Lauridsen   +11 more
doaj   +1 more source

Human monoclonal antibody combination against SARS coronavirus : synergy and coverage of escape mutants [PDF]

open access: yes, 2006
Background: Experimental animal data show that protection against severe acute respiratory syndrome coronavirus (SARS-CoV) infection with human monoclonal antibodies (mAbs) is feasible.
Cox Freek   +79 more
core   +1 more source

Factors associated with isolated anti-SARS-CoV-2 antibodies.

open access: yes, 2022
Factors associated with isolated anti-SARS-CoV-2 antibodies.
Woottichai Khamduang (147028)   +11 more
core   +1 more source

Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia

open access: yesInternational Journal of Infectious Diseases, 2021
: Background: As healthcare workers (HCWs) are at high risk for infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), they have priority for receipt of the coronavirus disease 2019 (COVID-19) vaccine.
Cucunawangsih Cucunawangsih   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy